Anti Cardiolipin IgM - India CDSCO Medical Device Registration

Anti Cardiolipin IgM is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000308_9f8f66b04f3280cc72a8688a3aa3ddf4_c6b2045f3324a663b6e8080bf1dc469a. This device is marketed under the brand name --. The license holder is Meril Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

Anti Cardiolipin IgM

UID: IMP/IVD/2019/000308_9f8f66b04f3280cc72a8688a3aa3ddf4_c6b2045f3324a663b6e8080bf1dc469a

Brand Name

License Holder

Meril Diagnostics Pvt. Ltd.

Device Class

Class B

Approving Authority

CDSCO

Product Information

Anti Cardiolipin IgM kit is an indirect solid phase immunoassay kit for the quantitative measurement of IgM class auto-antibodies directed against Cardiolipina-beta 2-glycoprotein complex in human serum or plasma

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Anti Cardiolipin IgM

Brand: Merilisa

Meril Diagnostics Pvt. Ltd.

Class B

Anti Cardiolipin IgM

M/s Vishat Diagnostic Pvt Ltd.

Class B

Brand: --

Meril Diagnostics Pvt. Ltd.

Class B

Brand: Gargle based

Class D